Disclosure of Statement of Deviation as per Regulation 32
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampure Specialty Sugars has filed a compliance statement confirming that proceeds from its preferential issue of warrants (approved by shareholders via EGM on 7 March 2024) have been used in line with the original purpose. The Audit Committee reviewed the fund utilization on 14 November 2025 for the quarter and half-year ended 30 September 2025. The company has reported zero deviation from the stated objects of the issue and zero variation between projected and actual use of funds. The filing was signed by Managing Director Sorabh Gupta. This is a routine regulatory disclosure required under SEBI's Listing Obligations and Disclosure Requirements Regulations.
This is a neutral, routine compliance filing with no negative implications. It reassures shareholders that money raised from the warrant allotment is being deployed as originally promised, with no misuse or diversion of funds. Investors should view this as good governance rather than a price-moving event.